EUVIMEDEUVIMED entdecken
Crossref

Real-World Accuracy of Continuous Glucose Monitoring During Intensive Hematological Care: A Prospective Study

Marieke Tienstra iD, Riemer A Been iD, Janneke W de Boer, Reinold O B Gans, André P van Beek, Hilde A M Kooistra, Valerie R Wiersma, Omar G Mustafa, Pratik Choudhary, Tom van Meerten, Peter R van Dijk

Diabetes Technology & Therapeutics · 2025

DOI: 10.1089/dia.2025.0232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Marieke Tienstra und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Blood Glucose, Hematologic Neoplasms, Hyperglycemia, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients treated for a hematological malignancy are susceptible to hyperglycemia, which can negatively affect treatment outcomes. Therefore, close monitoring of glucose levels is crucial. Data demonstrated that capillary measurement methods underreport hyperglycemic episodes compared with continuous glucose monitoring (CGM). However, the accuracy of CGM during intensive hematological treatments, and the associated metabolic and hemostatic imbalances, is unknown, which we aim to investigate in the current study.

Methods

For the analysis, data collected during a prospective study that compared CGM with capillary point-of-care (POC) glucose measurements in adult patients hospitalized for intensive hematological care with three different treatment modalities, namely chimeric antigen receptor T-cell therapy, allogeneic stem cell transplantation (allo-SCT), or autologous stem cell transplantation (auto-SCT), were used. POC and CGM measurements were performed concurrently. Accuracy was assessed using mean and median absolute relative difference (MARD), Diabetes Technology Society (DTS) Error Grid analysis as well as percentages of values within 15%/15, 20%/20, and 30%/30 mg/dL.

Results

A total of 60 patients (28% female, median age 64 [58–68] years and 10% with a history of diabetes mellitus) were included, yielding 1999 matched measurement pairs. The overall mean ARD was 21.5%, whereby the lowest mean ARD was observed during allo-SCT (18.3%) and the highest mean ARD during auto-SCT (27.1%). The percentages of glucose values within 15%/15, 20%/20, and 30%/30 mg/dL agreements were 38.1%, 51.1%, and 75.1%. The DTS Error Grid analysis showed good clinical accuracy with 99.6% of pairs within zone A + B.

Conclusions

Despite the relative high MARD, the use of CGM is unlikely to result in harmful insulin dosing errors and seems feasible to use during intensive hematological care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseHematologic NeoplasmsHyperglycemiaBlood Glucose Self-MonitoringHumansFemaleMiddle AgedMaleProspective StudiesAgedPoint-of-Care SystemsPoint-of-Care TestingMonitoring, PhysiologicCritical CareContinuous Glucose Monitoring

Stichwörter der Autor:innen

CGM accuracycontinuous glucose monitoringhospitalizationimmunology

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Diabetes, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • King's College London, London, United Kingdom.
  • Diabetes Research Center, University of Leicester, Leicester, United Kingdom.

ORCID-Profile: Marieke Tienstra, Riemer A Been

Zitieren

APA

Tienstra, M., Been, R. A., Boer, J. W., Gans, R. O. B., van Beek, A. P., Kooistra, H. A. M., Wiersma, V. R., Mustafa, O. G., Choudhary, P., van Meerten, T., & van Dijk, P. R. (2025). Real-World Accuracy of Continuous Glucose Monitoring During Intensive Hematological Care: A Prospective Study. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2025.0232

Vancouver

Tienstra M, Been RA, Boer JW, Gans ROB, van Beek AP, Kooistra HAM, et al. Real-World Accuracy of Continuous Glucose Monitoring During Intensive Hematological Care: A Prospective Study. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2025.0232

BibTeX
@article{Tienstra2025,
  author = {Tienstra, Marieke and Been, Riemer A and Boer, Janneke W de and Gans, Reinold O B and van Beek, André P and Kooistra, Hilde A M and Wiersma, Valerie R and Mustafa, Omar G and Choudhary, Pratik and van Meerten, Tom and van Dijk, Peter R},
  title = {Real-World Accuracy of Continuous Glucose Monitoring During Intensive Hematological Care: A Prospective Study},
  journal = {Diabetes Technology & Therapeutics},
  year = {2025},
  doi = {10.1089/dia.2025.0232}
}
Kostenlos starten →